These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9158937)

  • 1. Foulds' dangerous idea revisited: the multistep development of tumors 40 years later.
    Klein G
    Folia Biol (Praha); 1996; 42(6):273-81. PubMed ID: 9158937
    [No Abstract]   [Full Text] [Related]  

  • 2. Foulds' dangerous idea revisited: the multistep development of tumors 40 years later.
    Klein G
    Adv Cancer Res; 1998; 72():1-23. PubMed ID: 9338072
    [No Abstract]   [Full Text] [Related]  

  • 3. p53 mutation heterogeneity in cancer.
    Soussi T; Lozano G
    Biochem Biophys Res Commun; 2005 Jun; 331(3):834-42. PubMed ID: 15865939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p63: oncogene or tumor suppressor?
    Mills AA
    Curr Opin Genet Dev; 2006 Feb; 16(1):38-44. PubMed ID: 16359856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targets of oncogenes and tumor suppressors: key for understanding basic mechanisms of carcinogenesis.
    Kopnin BP
    Biochemistry (Mosc); 2000 Jan; 65(1):2-27. PubMed ID: 10702637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cancer cells. Genetic anomalies (oncogenes and anti-oncogenes), growth factors, apoptosis and dissemination, prognostic impact].
    Blay JY; Puisieux A
    Rev Prat; 2000 May; 50(10):1135-44. PubMed ID: 10905101
    [No Abstract]   [Full Text] [Related]  

  • 7. The p53 paradox in the pathogenesis of tumor progression.
    Holden RJ; Mooney PA
    Med Hypotheses; 1999 May; 52(5):483-5. PubMed ID: 10416957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of cancer progression.
    Michor F; Iwasa Y; Nowak MA
    Nat Rev Cancer; 2004 Mar; 4(3):197-205. PubMed ID: 14993901
    [No Abstract]   [Full Text] [Related]  

  • 9. Oncogene addiction versus oncogene amnesia: perhaps more than just a bad habit?
    Felsher DW
    Cancer Res; 2008 May; 68(9):3081-6; discussion 3086. PubMed ID: 18451131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oncogenes and tumor suppressor genes in the development of colonic tumors].
    Maeda Y; Miyaki M
    Nihon Naika Gakkai Zasshi; 1992 May; 81(5):643-8. PubMed ID: 1355100
    [No Abstract]   [Full Text] [Related]  

  • 11. The p53 saga: the good, the bad, and the dead.
    Oren M
    Harvey Lect; 2001-2002; 97():57-82. PubMed ID: 14562517
    [No Abstract]   [Full Text] [Related]  

  • 12. The somatic mutation theory of cancer: growing problems with the paradigm?
    Soto AM; Sonnenschein C
    Bioessays; 2004 Oct; 26(10):1097-107. PubMed ID: 15382143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oncogenes and tumor suppressor genes: general features].
    Piccinin S; Vukosavljevic T
    Acta Otorhinolaryngol Ital; 1996 Jun; 16(3 Suppl 54):17-20. PubMed ID: 9036735
    [No Abstract]   [Full Text] [Related]  

  • 14. [TP53 mutations and molecular epidemiology].
    Otsuka K; Ishioka C
    Gan To Kagaku Ryoho; 2007 May; 34(5):683-9. PubMed ID: 17496437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosensitivity of tumor cells. Oncogenes and apoptosis.
    Peltenburg LT
    Q J Nucl Med; 2000 Dec; 44(4):355-64. PubMed ID: 11302264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenes and tumor suppressor genes as paradigms in oncogenesis.
    Spandidos DA
    J BUON; 2007 Sep; 12 Suppl 1():S9-12. PubMed ID: 17935284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53-induced apoptosis as a safeguard against cancer.
    Asker C; Wiman KG; Selivanova G
    Biochem Biophys Res Commun; 1999 Nov; 265(1):1-6. PubMed ID: 10548481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic alterations in human prostate cancer: a review of current literature.
    Ozen M; Pathak S
    Anticancer Res; 2000; 20(3B):1905-12. PubMed ID: 10928125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis and cancer mechanisms.
    Pan H; Yin C; Van Dyke T
    Cancer Surv; 1997; 29():305-27. PubMed ID: 9338106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions.
    Pavelić K; Dedivitis RA; Kapitanović S; Cacev T; Guirado CR; Danić D; Radosević S; Brkić K; Pegan B; Krizanac S; Kusić Z; Spaventi S; Bura M
    Mutat Res; 2006 Jul; 599(1-2):45-57. PubMed ID: 16698048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.